Physician profile
David Fishman
NPI 1437386430
$1,935.73
in general payments reported to CMS, 2019-2025
19 companies · $583 in 2025
The $583 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $224 · 2021: $332 · 2022: $170 · 2023: $97.06 · 2024: $293 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856 · Travel and Lodging: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.38 |
| Travel and Lodging | $116.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $317.48 | 2021-2025 | Symplicity G3 |
| Shockwave Medical, INC | $262.48 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $249.03 | 2019-2025 | |
| Abiomed | $204.80 | 2024-2025 | Impella |
| Chiesi USA, INC. | $175.59 | 2019 | |
| Heartflow, INC. | $137.17 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $117.03 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.21 | 2022-2025 | Lifevest |
| Pfizer INC. | $54.18 | 2021-2023 | |
| Amgen INC. | $53.15 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $50.16 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.94 | 2020-2021 | |
| Philips North America LLC | $39.83 | 2021 | |
| Janssen Pharmaceuticals, INC | $35.14 | 2020-2021 | |
| Boston Scientific Corporation | $29.79 | 2020-2023 | Watchman Flx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $25.27 | 2019 | |
| Inari Medical, INC. | $22.22 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $18.57 | 2020 | |
| Cardiovascular Systems INC. | $16.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.